Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
暂无分享,去创建一个
S Somavarapu | H. Alpár | Vincent W. Bramwell | S. Somavarapu | K. Atuah | H Oya Alpar | K N Atuah | V W Bramwell
[1] V E Schijns,et al. Immunological concepts of vaccine adjuvant activity. , 2000, Current opinion in immunology.
[2] J. Eldridge,et al. Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response. , 1989, Advances in experimental medicine and biology.
[3] P. Ogra. Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus. , 1971, The New England journal of medicine.
[4] M. D. de Jong,et al. Herd immunity after vaccination: how to quantify it and how to use it to halt disease. , 2001, Vaccine.
[5] R. Chanock,et al. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus , 1983, Infection and immunity.
[6] N. Restifo. Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunity. , 2000, Current opinion in immunology.
[7] H. Alpár,et al. Intranasal vaccination against plague, tetanus and diphtheria. , 2001, Advanced drug delivery reviews.
[8] H. Lassmann,et al. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials , 1999, Nature Medicine.
[9] C. Caruso,et al. Major histocompatibility complex regulation of cytokine production. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[10] H. Alpár,et al. Current status of DNA vaccines and their route of administration. , 2002, Critical reviews in therapeutic drug carrier systems.
[11] C. Dibble,et al. The role of international environmental agreements in metered-dose inhaler technology changes. , 1999, The Journal of allergy and clinical immunology.
[12] H. Merkle,et al. Cationic stearylamine-containing biodegradable microparticles for DNA delivery , 2004, Journal of microencapsulation.
[13] M. R. Brown,et al. Antimicrobial properties of liposomal polymyxin B. , 1999, The Journal of antimicrobial chemotherapy.
[14] G. Scheuch,et al. In vitro testing of two formoterol dry powder inhalers at different flow rates. , 2002, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[15] R. Herrero-Vanrell,et al. Enhancement of the mydriatic response to tropicamide by bioadhesive polymers. , 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[16] C. Ehrhardt,et al. Large Porous Particle Impingement on Lung Epithelial Cell Monolayers—Toward Improved Particle Characterization in the Lung , 2003, Pharmaceutical Research.
[17] M. Svartengren,et al. Inhalation and deposition of nebulized sodium cromoglycate in two different particle size distributions in children with asthma , 2002, Pediatric pulmonology.
[18] R. Lynch,et al. Differential Induction of Mucosal and Systemic Antibody Responses in Women After Nasal, Rectal, or Vaginal Immunization: Influence of the Menstrual Cycle1 , 2002, The Journal of Immunology.
[19] P. Veski,et al. Evaluation of microcrystalline chitosans for gastro-retentive drug delivery. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[20] J. Fowler,et al. Peristomal allergic contact dermatitis due to Gantrez in Stomahesive paste. , 2000, Journal of the American Academy of Dermatology.
[21] R. Roden,et al. Nasal Immunization of Mice with Human Papillomavirus Type 16 Virus-Like Particles Elicits Neutralizing Antibodies in Mucosal Secretions , 1998, Journal of Virology.
[22] Mandip Singh,et al. Evaluation of the Malvern Spraytec with inhalation cell for the measurement of particle size distribution from metered dose inhalers. , 2004, Journal of pharmaceutical sciences.
[23] Y. Makino,et al. Mucoadhesive beclomethasone microspheres for powder inhalation: their pharmacokinetics and pharmacodynamics evaluation. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[24] Vincent W. Bramwell,et al. Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen , 2002, Immunology.
[25] Y. Makino,et al. Enhanced pulmonary absorption following aerosol administration of mucoadhesive powder microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[26] R. Kradin,et al. The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen , 1995, The Journal of experimental medicine.
[27] J. Brussee,et al. Preparation and NMR characterization of highly substitutedN-trimethyl chitosan chloride , 1998 .
[28] A. Gebert,et al. M cells at locations outside the gut. , 1999, Seminars in immunology.
[29] I. Lorenz,et al. The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine. , 2003, Vaccine.
[30] F. Marincola,et al. Cancer therapy using a self-replicating RNA vaccine , 1999, Nature Medicine.
[31] J. Holmgren,et al. Nasal and Vaginal Vaccinations Have Differential Effects on Antibody Responses in Vaginal and Cervical Secretions in Humans , 2001, Infection and Immunity.
[32] J. Henriksson,et al. Uptake of cobalt from the nasal mucosa into the brain via olfactory pathways in rats. , 2003, Toxicology letters.
[33] Hugh D C Smyth,et al. The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers. , 2003, Advanced drug delivery reviews.
[34] H. Staats,et al. Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses. , 1997, AIDS research and human retroviruses.
[35] A. Almeida,et al. Microsphere absorption by the nasal mucosa of the rat. , 1994, Journal of drug targeting.
[36] M Keller,et al. Innovations and perspectives of metered dose inhalers in pulmonary drug delivery. , 1999, International journal of pharmaceutics.
[37] Vincent W. Bramwell,et al. Stimulation of spleen cells in vitro by nanospheric particles containing antigen. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[38] Preparation of microcapsules from complex coacervation of Gantrez-gelatin. III. Bioavailability of nitrofurantoin microcapsules. , 1988, Journal of microencapsulation.
[39] Clark,et al. Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52 , 1998, Immunology.
[40] Krishnendu Roy,et al. Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.
[41] J. Mcghee,et al. Peyer's patches are required for oral tolerance to proteins , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[42] H. Junginger,et al. N-Trimethylated Chitosan Chloride (TMC) Improves the Intestinal Permeation of the Peptide Drug Buserelin In Vitro (Caco-2 Cells) and In Vivo (Rats) , 2004, Pharmaceutical Research.
[43] M. Russell,et al. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system , 1997, Immunologic research.
[44] P. Brandtzaeg,et al. Mucosal Immunology of the Upper Airways: An Overview a , 1997, Annals of the New York Academy of Sciences.
[45] J. Lanciego,et al. Multiple neuroanatomical tracing in primates. , 1998, Brain research. Brain research protocols.
[46] David M. Mosser,et al. Cutting Edge: Biasing Immune Responses by Directing Antigen to Macrophage Fcγ Receptors1 , 2002, The Journal of Immunology.
[47] D. Bout,et al. Intranasal Immunization with Toxoplasma gondii SAG1 Induces Protective Cells into Both NALT and GALT Compartments , 2000, Infection and Immunity.
[48] H. Staats,et al. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). , 1996, Journal of immunology.
[49] Gerrit Borchard,et al. Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis. , 2004, Vaccine.
[50] Waldrep Jc. New aerosol drug delivery systems for the treatment of immune-mediated pulmonary diseases. , 1998 .
[51] A. Sabin. Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[52] R. Langer,et al. Formulation and Physical Characterization of Large Porous Particles for Inhalation , 1999, Pharmaceutical Research.
[53] N. Lycke. From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1‐DD/ISCOM , 2004, Cellular microbiology.
[54] A. Bernkop‐Schnürch,et al. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[55] J. Hanes,et al. New polymeric carriers for controlled drug delivery following inhalation or injection. , 2002, Biomaterials.
[56] J. Kaldor,et al. The causal link between human papillomavirus and invasive cervical cancer: A population‐based case‐control study in colombia and spain , 1992, International journal of cancer.
[57] A. Almeida,et al. Nasal delivery of vaccines. , 1996, Journal of drug targeting.
[58] R. Tharanathan,et al. Chitin — The Undisputed Biomolecule of Great Potential , 2003, Critical reviews in food science and nutrition.
[59] F. Szoka,et al. Efficiency of Cytoplasmic Delivery by pH-Sensitive Liposomes to Cells in Culture , 1990, Pharmaceutical Research.
[60] B. Murphy,et al. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. , 1995, Vaccine.
[61] W. Lencer,et al. Membrane traffic and the cellular uptake of cholera toxin. , 1999, Biochimica et biophysica acta.
[62] D A Groneberg,et al. Fundamentals of pulmonary drug delivery. , 2003, Respiratory medicine.
[63] Arturo Casadevall,et al. Antibody-mediated regulation of cellular immunity and the inflammatory response. , 2003, Trends in immunology.
[64] Liposomes as immunological adjuvants , 1974 .
[65] H. Adami,et al. Infections as a major preventable cause of human cancer , 2000, Journal of internal medicine.
[66] Gerene M. Denning,et al. Inhibition of Ca2+ Signaling by Mycobacterium tuberculosisIs Associated with Reduced Phagosome–Lysosome Fusion and Increased Survival within Human Macrophages , 2000, The Journal of experimental medicine.
[67] J. Mcghee,et al. Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues , 2000, The Journal of Immunology.
[68] Y. Oh,et al. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus‐like particle vaccine in thermosensitive mucoadhesive delivery systems , 2003, Journal of medical virology.
[69] Y. Kawashima,et al. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. , 2003, Journal of Controlled Release.
[70] P. Barkvoll,et al. Antiplaque, antibacterial, and anti-inflammatory properties of triclosan mouthrinses in combination with zinc citrate or polyvinylmethylether maleic acid (PVM-MA) copolymer. , 1996, European journal of oral sciences.
[71] H. Alpar,et al. Effectiveness of liposomes as adjuvants of orally and nasally administered tetanus toxoid , 1992 .
[72] M. Wirth,et al. Gantrez AN as a new polymer for the preparation of ligand-nanoparticle conjugates. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[73] K. Uekama,et al. Improvement of nasal bioavailability of luteinizing hormone-releasing hormone agonist, buserelin, by cyclodextrin derivatives in rats. , 1995, Journal of pharmaceutical sciences.
[74] C. Lehr,et al. Lectin-mediated drug delivery: the second generation of bioadhesives. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[75] H. Tamura,et al. Immunological aspects of chitin and chitin derivatives administered to animals. , 1999, EXS.
[76] H. Junginger,et al. Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[77] M. Gamble,et al. A comparative study on the pulmonary delivery of tobramycin encapsulated into liposomes and PLA microspheres following intravenous and endotracheal delivery , 1995 .
[78] G. Raghava,et al. Measurement and computation of murine interleukin-4 and interferon-gamma by exploiting the unique abilities of these lymphokines to induce the secretion of IgG1 and IgG2a. , 1993, Journal of immunoassay.
[79] H. Junginger,et al. Oral drug absorption enhancement by chitosan and its derivatives. , 2001, Advanced drug delivery reviews.
[80] J. Eyles,et al. Tissue distribution of radioactivity following intranasal administration of radioactive microspheres , 2001, The Journal of pharmacy and pharmacology.
[81] K. Uekama,et al. Cyclodextrins in peptide and protein delivery. , 1999, Advanced drug delivery reviews.
[82] H. Junginger,et al. Effects of N-trimethyl chitosan chloride, a novel absorption enhancer, on caco-2 intestinal epithelia and the ciliary beat frequency of chicken embryo trachea. , 1999, International journal of pharmaceutics.
[83] L. Frati,et al. CD44 triggering enhances human NK cell cytotoxic functions. , 1994, Journal of immunology.
[84] L. Huang,et al. DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. , 1994, Biochimica et biophysica acta.
[85] M. Parry-Billings,et al. The inhalers of the future? A review of dry powder devices on the market today. , 2003, Pulmonary pharmacology & therapeutics.
[86] J. Holmgren,et al. Antibody Responses in the Lower Respiratory Tract and Male Urogenital Tract in Humans after Nasal and Oral Vaccination with Cholera Toxin B Subunit , 1999, Infection and Immunity.
[87] Preparation of microcapsules from complex coacervation of Gantrez-gelatin. II. In vitro dissolution of nitrofurantoin microcapsules. , 1987, Journal of microencapsulation.
[88] L. Hyland,et al. Nasal-Associated Lymphoid Tissue Is a Site of Long-Term Virus-Specific Antibody Production following Respiratory Virus Infection of Mice , 2001, Journal of Virology.
[89] J. Tsibouklis,et al. Polymeric microspheres for drug delivery to the oral cavity: an in vitro evaluation of mucoadhesive potential. , 2003, Journal of pharmaceutical sciences.
[90] J. Holmgren,et al. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina , 1997, Infection and immunity.
[91] A. Velardi,et al. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells. , 1994, Journal of immunology.
[92] J. Biewenga,et al. The role of nasopharyngeal lymphoid tissue. , 1992, Immunology today.
[93] H. Alpár,et al. Oral Plasmid DNA Delivery Systems for Genetic Immunisation , 2003, Journal of drug targeting.
[94] G. Gregoriadis,et al. Liposome-mediated DNA vaccination: the effect of vesicle composition. , 2001, Vaccine.
[95] Gerrit Borchard,et al. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro , 1996 .
[96] R. Rappuoli,et al. Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines , 2003, Expert review of vaccines.
[97] Y Wang,et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[98] Y. Capan,et al. Preparation and Characterization of Poly (D,L-Lactide-Co-Glycolide) Microspheres for Controlled Release of Poly(L-Lysine) Complexed Plasmid DNA , 1999, Pharmaceutical Research.
[99] A. Gebert,et al. Kinetics of particle uptake in the domes of Peyer's patches. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[100] G. Scheuch,et al. In vitro and in vivo dose delivery characteristics of large porous particles for inhalation. , 2002, International journal of pharmaceutics.
[101] Lisbeth Illum,et al. Chitosan as a Novel Nasal Delivery System for Peptide Drugs , 1994, Pharmaceutical Research.
[102] Hans E. Junginger,et al. Mucoadhesive Polymers in Peroral Peptide Drug Delivery. VI. Carbomer and Chitosan Improve the Intestinal Absorption of the Peptide Drug Buserelin In Vivo , 1996, Pharmaceutical Research.
[103] J. Eyles,et al. Immunological responses to nasal delivery of free and encapsulated tetanus toxoid: studies on the effect of vehicle volume. , 1999, International journal of pharmaceutics.
[104] R. Muzzarelli,et al. Biochemistry, histology and clinical uses of chitins and chitosans in wound healing. , 1999, EXS.
[105] P. Brandtzaeg,et al. Human nasal mucosa contains antigen-presenting cells of strikingly different functional phenotypes. , 2004, American journal of respiratory cell and molecular biology.
[106] H. Alpar,et al. Do interactions with phospholipids contribute to the prolonged retention of polypeptides within the lung , 1996 .
[107] L. Lunsford,et al. Tissue Distribution and Persistence in Mice of Plasmid DNA Encapsulated in a PLGA-Based Microsphere Delivery Vehicle , 2000, Journal of drug targeting.
[108] S. Kato,et al. Strain-dependent antibody response induced by DNA immunization. , 2000, Immunology letters.
[109] S. Rossi,et al. Assessment of chitosan derivatives as buccal and vaginal penetration enhancers. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[110] G. Icardi,et al. Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres. , 2002, Vaccine.
[111] M. Russell,et al. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit , 1993, Infection and immunity.
[112] Vincent W. Bramwell,et al. Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration. , 2001, Vaccine.
[113] Lisbeth Illum,et al. Absorption Enhancers for Nasal Drug Delivery , 2003, Clinical pharmacokinetics.
[114] P. Hogarth,et al. Cutting Edge: Identification of the Mouse IgG3 Receptor: Implications for Antibody Effector Function at the Interface Between Innate and Adaptive Immunity , 1998, The Journal of Immunology.
[115] P. Holt,et al. A contiguous network of dendritic antigen-presenting cells within the respiratory epithelium. , 1990, International archives of allergy and applied immunology.
[116] H. Merkle,et al. Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods. , 2003, Journal of microencapsulation.
[117] Y. Kawashima,et al. Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes , 1996, Pharmaceutical Research.
[118] F. Szoka,et al. Mechanism of oligonucleotide release from cationic liposomes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[119] D. D. Ourth. Neutralization of diphtheria toxin by human immunoglobulin classes and subunits. , 1974, Immunochemistry.
[120] G. Smaldone,et al. Effect of tubing deposition, breathing pattern, and temperature on aerosol mass distribution measured by cascade impactor. , 2003, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[121] S. Demotz,et al. Trachea, Lung, and Tracheobronchial Lymph Nodes Are the Major Sites Where Antigen-Presenting Cells Are Detected after Nasal Vaccination of Mice with Human Papillomavirus Type 16 Virus-Like Particles , 2002, Journal of Virology.
[122] G. P. Martin,et al. Transition to CFC-free metered dose inhalers--into the new millennium. , 2000, International journal of pharmaceutics.
[123] M. Lubeck,et al. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon. , 1984, Cancer research.
[124] A. Mitra,et al. Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts. , 2000, International journal of pharmaceutics.
[125] L. Samaranayake,et al. Experimental Oral Candidiasis in Animal Models , 2001, Clinical Microbiology Reviews.
[126] N Lotan,et al. Large porous particles for pulmonary drug delivery. , 1997, Science.
[127] A. Almeida,et al. Immune Response to Nasal Delivery of Antigenically Intact Tetanus Toxoid Associated with Poly(l‐lactic acid) Microspheres in Rats, Rabbits and Guinea‐pigs , 1993, The Journal of pharmacy and pharmacology.
[128] T. Martonen,et al. Factors affecting the deposition of inhaled porous drug particles. , 2002, Journal of pharmaceutical sciences.
[129] M. J. Staruch,et al. Genetic influences on the adjuvanticity of muramyl dipeptide in vivo. , 1982, Journal of immunology.
[130] Véronique Préat,et al. Alveolar macrophages are a primary barrier to pulmonary absorption of macromolecules. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[131] I. Maridonneau-Parini,et al. The Mannose Receptor Mediates Uptake of Pathogenic and Nonpathogenic Mycobacteria and Bypasses Bactericidal Responses in Human Macrophages , 1999, Infection and Immunity.
[132] H. Junginger,et al. Mucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro , 1997 .
[133] J. Eyles,et al. Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse. , 1998, Vaccine.
[134] K. Sotlar,et al. Life Cycle Heterogeneity in Animal Models of Human Papillomavirus-Associated Disease , 2002, Journal of Virology.
[135] D. Yuan,et al. The functional relevance of NK-cell-mediated upregulation of antigen-specific IgG2a responses. , 2000, Cellular immunology.
[136] R. Condos,et al. Lung deposition and respirable mass during wet nebulization. , 2003, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[137] H. D. Liggitt,et al. Aerosol Delivery of Lipid:DNA Complexes to Lungs of Rhesus Monkeys , 1998, Pharmaceutical Research.